Literature DB >> 26286675

Classifying ADRs--does dose matter?

Elizabeth J Phillips1,2.   

Abstract

Mesh：

Year:  2015        PMID： 26286675      PMCID： PMC4693569          DOI： 10.1111/bcp.12749

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  15 in total

1.  Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.

Authors:  Patricia T Illing; Julian P Vivian; Nadine L Dudek; Lyudmila Kostenko; Zhenjun Chen; Mandvi Bharadwaj; John J Miles; Lars Kjer-Nielsen; Stephanie Gras; Nicholas A Williamson; Scott R Burrows; Anthony W Purcell; Jamie Rossjohn; James McCluskey
Journal:  Nature       Date:  2012-06-28       Impact factor: 49.962

2.  Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire.

Authors:  David A Ostrov; Barry J Grant; Yuri A Pompeu; John Sidney; Mikkel Harndahl; Scott Southwood; Carla Oseroff; Shun Lu; Jean Jakoncic; Cesar Augusto F de Oliveira; Lun Yang; Hu Mei; Leming Shi; Jeffrey Shabanowitz; A Michelle English; Amanda Wriston; Andrew Lucas; Elizabeth Phillips; Simon Mallal; Howard M Grey; Alessandro Sette; Donald F Hunt; Soren Buus; Bjoern Peters
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

3.  Classifying ADRs--does dose matter?

Authors:  Elizabeth J Phillips
Journal:  Br J Clin Pharmacol       Date:  2015-11-02       Impact factor: 4.335

Review 4.  The law of mass action and the pharmacological concentration-effect curve: resolving the paradox of apparently non-dose-related adverse drug reactions.

Authors:  Jeffrey K Aronson; Robin E Ferner
Journal:  Br J Clin Pharmacol       Date:  2015-10-26       Impact factor: 4.335

5.  Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin.

Authors:  Wen-Hung Chung; Wan-Chun Chang; Sophie L Stocker; Chiun-Gung Juo; Garry G Graham; Ming-Han H Lee; Kenneth M Williams; Ya-Chung Tian; Kuo-Chang Juan; Yeong-Jian Jan Wu; Chih-Hsun Yang; Chee-Jen Chang; Yu-Jr Lin; Richard O Day; Shuen-Iu Hung
Journal:  Ann Rheum Dis       Date:  2014-08-12       Impact factor: 19.103

6.  Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan.

Authors:  Pei Chen; Juei-Jueng Lin; Chin-Song Lu; Cheung-Ter Ong; Peiyuan F Hsieh; Chih-Chao Yang; Chih-Ta Tai; Shey-Lin Wu; Cheng-Hsien Lu; Yung-Chu Hsu; Hsiang-Yu Yu; Long-Sun Ro; Chung-Ta Lu; Chun-Che Chu; Jing-Jane Tsai; Yu-Hsiang Su; Sheng-Hsing Lan; Sheng-Feng Sung; Shu-Yi Lin; Hui-Ping Chuang; Li-Chen Huang; Ying-Ju Chen; Pei-Joung Tsai; Hung-Ting Liao; Yu-Hsuan Lin; Chien-Hsiun Chen; Wen-Hung Chung; Shuen-Iu Hung; Jer-Yuarn Wu; Chi-Feng Chang; Luke Chen; Yuan-Tsong Chen; Chen-Yang Shen
Journal:  N Engl J Med       Date:  2011-03-24       Impact factor: 91.245

7.  Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent.

Authors:  Jing Yuan; Sheng Guo; David Hall; Anna M Cammett; Supriya Jayadev; Manuel Distel; Stephen Storfer; Zimei Huang; Piroon Mootsikapun; Kiat Ruxrungtham; Daniel Podzamczer; David W Haas
Journal:  AIDS       Date:  2011-06-19       Impact factor: 4.177

8.  Genetic variants associated with phenytoin-related severe cutaneous adverse reactions.

Authors:  Wen-Hung Chung; Wan-Chun Chang; Yun-Shien Lee; Ying-Ying Wu; Chih-Hsun Yang; Hsin-Chun Ho; Ming-Jing Chen; Jing-Yi Lin; Rosaline Chung-Yee Hui; Ji-Chen Ho; Wei-Ming Wu; Ting-Jui Chen; Tony Wu; Yih-Ru Wu; Mo-Song Hsih; Po-Hsun Tu; Chen-Nen Chang; Chien-Ning Hsu; Tsu-Lan Wu; Siew-Eng Choon; Chao-Kai Hsu; Der-Yuan Chen; Chin-San Liu; Ching-Yuang Lin; Nahoko Kaniwa; Yoshiro Saito; Yukitoshi Takahashi; Ryosuke Nakamura; Hiroaki Azukizawa; Yongyong Shi; Tzu-Hao Wang; Shiow-Shuh Chuang; Shih-Feng Tsai; Chee-Jen Chang; Yu-Sun Chang; Shuen-Iu Hung
Journal:  JAMA       Date:  2014-08-06       Impact factor: 56.272

9.  HLA-B*5701 screening for hypersensitivity to abacavir.

Authors:  Simon Mallal; Elizabeth Phillips; Giampiero Carosi; Jean-Michel Molina; Cassy Workman; Janez Tomazic; Eva Jägel-Guedes; Sorin Rugina; Oleg Kozyrev; Juan Flores Cid; Phillip Hay; David Nolan; Sara Hughes; Arlene Hughes; Susanna Ryan; Nicholas Fitch; Daren Thorborn; Alastair Benbow
Journal:  N Engl J Med       Date:  2008-02-07       Impact factor: 91.245

10.  Abacavir-reactive memory T cells are present in drug naïve individuals.

Authors:  Andrew Lucas; Michaela Lucas; Anette Strhyn; Niamh M Keane; Elizabeth McKinnon; Rebecca Pavlos; Ellen M Moran; Viola Meyer-Pannwitt; Silvana Gaudieri; Lloyd D'Orsogna; Spyros Kalams; David A Ostrov; Søren Buus; Bjoern Peters; Simon Mallal; Elizabeth Phillips
Journal:  PLoS One       Date:  2015-02-12       Impact factor: 3.240
View more
  13 in total

1.  Classifying ADRs--does dose matter?

Authors:  Elizabeth J Phillips
Journal:  Br J Clin Pharmacol       Date:  2015-11-02       Impact factor: 4.335

Review 2.  Antibiotic Allergy in Pediatrics.

Authors:  Allison Eaddy Norton; Katherine Konvinse; Elizabeth J Phillips; Ana Dioun Broyles
Journal:  Pediatrics       Date:  2018-05       Impact factor: 7.124

Review 3.  The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration.

Authors:  Jason A Trubiano; Cosby A Stone; M Lindsay Grayson; Karen Urbancic; Monica A Slavin; Karin A Thursky; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2017-08-23

Review 4.  [Acute hypersensitivity reactions associated with monoclonal antibodies for targeted therapy].

Authors:  B Sachs; H F Merk
Journal:  Hautarzt       Date:  2018-04       Impact factor: 0.751

Review 5.  Antibiotic allergy labels in hospitalized and critically ill adults: A review of current impacts of inaccurate labelling.

Authors:  Rebekah Moran; Misha Devchand; Olivia Smibert; Jason A Trubiano
Journal:  Br J Clin Pharmacol       Date:  2019-01-11       Impact factor: 4.335

Review 6.  Genetic Basis of Delayed Hypersensitivity Reactions to Drugs in Jewish and Arab Populations.

Authors:  Mohammed Aboukaoud; Shoshana Israel; Chaim Brautbar; Sara Eyal
Journal:  Pharm Res       Date:  2018-09-17       Impact factor: 4.200

Review 7.  Pharmacogenomics of off-target adverse drug reactions.

Authors:  Sarah L Garon; Rebecca K Pavlos; Katie D White; Nancy J Brown; Cosby A Stone; Elizabeth J Phillips
Journal:  Br J Clin Pharmacol       Date:  2017-04-27       Impact factor: 4.335

Review 8.  Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.

Authors:  Jonathan Grant Peter; Rannakoe Lehloenya; Sipho Dlamini; Kimberly Risma; Katie D White; Katherine C Konvinse; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2017 May - Jun

9.  The prevalence and impact of antimicrobial allergies and adverse drug reactions at an Australian tertiary centre.

Authors:  Jason A Trubiano; Kelly A Cairns; Jacqui A Evans; Amally Ding; Tuan Nguyen; Michael J Dooley; Allen C Cheng
Journal:  BMC Infect Dis       Date:  2015-12-16       Impact factor: 3.090

10.  A web resource for mining HLA associations with adverse drug reactions: HLA-ADR.

Authors:  Gurpreet S Ghattaoraya; Yenal Dundar; Faviel F González-Galarza; Maria Helena Thomaz Maia; Eduardo José Melo Santos; Andréa Luciana Soares da Silva; Antony McCabe; Derek Middleton; Ana Alfirevic; Rumona Dickson; Andrew R Jones
Journal:  Database (Oxford)       Date:  2016-05-17       Impact factor: 3.451
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.